SUBSCRIBE
SUBSCRIBE
Gail Dutton

Gail Dutton

Freelance writer

Gail Dutton is a veteran biopharmaceutical reporter, covering the industry from Washington state. You can contact her at gaildutton@gmail.com and see more of her work on Muckrack.

Win McNamee/Getty Images
Policy
FDA Issues Final Master Protocols Guidance for COVID-19 Drugs and Vaccines
The guidance takes effect immediately and will remain in effect throughout the pandemic.
May 17, 2021
 · 
4 min read
 · 
Gail Dutton
Genetown
Cellino Develops Scalable, Closed-Loop System for Autologous Stem Cell Manufacturing
Cellino’s unique blend of lasers and machine learning is transforming the manufacture of autologous stem cell therapies from an inconsistent hand-crafted endeavor to a scalable, efficient, closed-loop, modern process.
May 14, 2021
 · 
4 min read
 · 
Gail Dutton
Genetown
No Chemicals, Heat or Irradiation Needed for Aphios’ Viral Inactivation Tech
Aphios International is developing a generally applicable pathogen reduction technology for pooled blood plasma and blood products, immunoglobulins, recombinant biologics and monoclonal antibodies used to treat cancer and COVID-19 patients.
May 13, 2021
 · 
4 min read
 · 
Gail Dutton
BioMidwest
Going to Work Could be Safer than Staying Home in a Pandemic, U of Chicago Study Finds
Staying at home during the COVID-19 pandemic actually increased the spread of infection, according to new study published by the University of Chicago and, soon, by the National Bureau of Economic Research.
May 12, 2021
 · 
4 min read
 · 
Gail Dutton
Drug Development
jCyte Announces Promising Phase IIb Results for Allogeneic Retinal Stem Cell Therapy
jCyte Inc. presented the results from its Phase IIb study and a detailed analysis of the study’s optical coherence tomography (OCT) data last week at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting.
May 10, 2021
 · 
4 min read
 · 
Gail Dutton
Drug Development
Australian Researchers Say Best COVID-19 Vaccines 58% Effective at 250 Days
Next year, people are likely to need an annual COVID-19 vaccination just like they need an annual flu shot.
May 4, 2021
 · 
5 min read
 · 
Gail Dutton
DEMO: Nanome Triggers Deep Drug Development Insights Via Virtual Molecule Design
If you equate virtual reality (VR) to games or pain relief applications, you’re missing one of science’s most amazing tools.
April 30, 2021
 · 
5 min read
 · 
Gail Dutton
Drug Development
Galectin Therapeutics Launches NASH Cirrhosis Info Site for Physicians and Patients
Galectin Therapeutics takes its role seriously, as perhaps the only company developing a therapy for non-alcoholic steatohepatitis (NASH) cirrhosis, an advanced form of NASH. Along with its Phase IIb/III clinical trial, it recently launched NAVIGATEnash.com.
April 27, 2021
 · 
4 min read
 · 
Gail Dutton
Deals
Biotech SPACs Can Expect a Good Runway as Investors Focus on Quality
Special Purpose Acquisition Companies (SPACs) are here to stay, offering one more way for companies to access public markets. But doing so isn’t a quick snap of the fingers.
April 26, 2021
 · 
5 min read
 · 
Gail Dutton
Policy
Death, Disability Among Side Effects of Chinese COVID-19 Vaccines, Leaked Documents Reveal
Leaked documents from provincial and municipal governments in China reveal a slew of previously unreported severe adverse events related to COVID-19 vaccines made and administered in China.
April 26, 2021
 · 
4 min read
 · 
Gail Dutton
Biotech Bay
Mission Bio Launches Assay Development Service for Single Cell Multiomics
Mission Bio just launched its Pharma Assay Development (PAD) service, enabling its customers to obtain early access services based on the newest technologies as well as on its existing products.
April 21, 2021
 · 
4 min read
 · 
Gail Dutton
Chromatin is the 3-dimensional structure of DNA, w
Business
Q&A: Foghorn SVP Expounds on “Tremendous Opportunity” in Chromatin Remodeling
BioSpace caught up Foghorn Therapeutics’ Steven Bellon, Ph.D., SVP, drug discovery, shortly before he chaired a panel on new epigenetic developments at the AACR Annual Meeting 2021.
April 20, 2021
 · 
4 min read
 · 
Gail Dutton
Tom Williams/CQ Roll Call
Business
Q&A with Acting FDA Commissioner Janet Woodcock on the Future of the FDA
Acting FDA Commissioner Janet Woodcock shared her thoughts on pandemic issues and outlined FDA modernization plans in a recent Q&A session with the Alliance for a Stronger FDA (Alliance).
April 19, 2021
 · 
5 min read
 · 
Gail Dutton
FDA
Celularity Gains FDA Orphan Drug Status on Strength of Placental Stem Cell Trials
On Tuesday, Celularity received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for its off-the-shelf natural killer cell therapy for malignant gliomas.
April 13, 2021
 · 
4 min read
 · 
Gail Dutton
AACR: OncoMyx Presents First Data Showing Myxoma Virotherapy Anti-Tumor Efficacy
The three posters OncoMyx Therapeutics presented at the virtual American Association for Cancer Research (AACR) Virtual Annual Meeting on April 10th provided the first data indicating its myxoma virotherapy approach to oncolytic therapeutics.
April 12, 2021
 · 
4 min read
 · 
Gail Dutton
Load More